Vaccines targeting
Breast cancer
cancer vaccines
estrogen receptor
immunotherapy
neoepitopes
preventative vaccination
resistance mutations
Journal
Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652
Informations de publication
Date de publication:
31 Dec 2024
31 Dec 2024
Historique:
medline:
9
2
2024
pubmed:
9
2
2024
entrez:
8
2
2024
Statut:
ppublish
Résumé
ER+ breast cancers (BC) are characterized by the elevated expression and signaling of estrogen receptor alpha (
Identifiants
pubmed: 38330990
doi: 10.1080/21645515.2024.2309693
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM